TRRAP_HUMAN - dbPTM
TRRAP_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TRRAP_HUMAN
UniProt AC Q9Y4A5
Protein Name Transformation/transcription domain-associated protein
Gene Name TRRAP
Organism Homo sapiens (Human).
Sequence Length 3859
Subcellular Localization Nucleus .
Protein Description Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation. Also involved in transcription activation mediated by the adenovirus E1A, a viral oncoprotein that deregulates transcription of key genes. Probably acts by linking transcription factors such as E1A, MYC or E2F1 to HAT complexes such as STAGA thereby allowing transcription activation. Probably not required in the steps following histone acetylation in processes of transcription activation. May be required for the mitotic checkpoint and normal cell cycle progression. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AFZ from the nucleosome..
Protein Sequence MAFVATQGATVVDQTTLMKKYLQFVAALTDVNTPDETKLKMMQEVSENFENVTSSPQYSTFLEHIIPRFLTFLQDGEVQFLQEKPAQQLRKLVLEIIHRIPTNEHLRPHTKNVLSVMFRFLETENEENVLICLRIIIELHKQFRPPITQEIHHFLDFVKQIYKELPKVVNRYFENPQVIPENTVPPPEMVGMITTIAVKVNPEREDSETRTHSIIPRGSLSLKVLAELPIIVVLMYQLYKLNIHNVVAEFVPLIMNTIAIQVSAQARQHKLYNKELYADFIAAQIKTLSFLAYIIRIYQELVTKYSQQMVKGMLQLLSNCPAETAHLRKELLIAAKHILTTELRNQFIPCMDKLFDESILIGSGYTARETLRPLAYSTLADLVHHVRQHLPLSDLSLAVQLFAKNIDDESLPSSIQTMSCKLLLNLVDCIRSKSEQESGNGRDVLMRMLEVFVLKFHTIARYQLSAIFKKCKPQSELGAVEAALPGVPTAPAAPGPAPSPAPVPAPPPPPPPPPPATPVTPAPVPPFEKQGEKDKEDKQTFQVTDCRSLVKTLVCGVKTITWGITSCKAPGEAQFIPNKQLQPKETQIYIKLVKYAMQALDIYQVQIAGNGQTYIRVANCQTVRMKEEKEVLEHFAGVFTMMNPLTFKEIFQTTVPYMVERISKNYALQIVANSFLANPTTSALFATILVEYLLDRLPEMGSNVELSNLYLKLFKLVFGSVSLFAAENEQMLKPHLHKIVNSSMELAQTAKEPYNYFLLLRALFRSIGGGSHDLLYQEFLPLLPNLLQGLNMLQSGLHKQHMKDLFVELCLTVPVRLSSLLPYLPMLMDPLVSALNGSQTLVSQGLRTLELCVDNLQPDFLYDHIQPVRAELMQALWRTLRNPADSISHVAYRVLGKFGGSNRKMLKESQKLHYVVTEVQGPSITVEFSDCKASLQLPMEKAIETALDCLKSANTEPYYRRQAWEVIKCFLVAMMSLEDNKHALYQLLAHPNFTEKTIPNVIISHRYKAQDTPARKTFEQALTGAFMSAVIKDLRPSALPFVASLIRHYTMVAVAQQCGPFLLPCYQVGSQPSTAMFHSEENGSKGMDPLVLIDAIAICMAYEEKELCKIGEVALAVIFDVASIILGSKERACQLPLFSYIVERLCACCYEQAWYAKLGGVVSIKFLMERLPLTWVLQNQQTFLKALLFVMMDLTGEVSNGAVAMAKTTLEQLLMRCATPLKDEERAEEIVAAQEKSFHHVTHDLVREVTSPNSTVRKQAMHSLQVLAQVTGKSVTVIMEPHKEVLQDMVPPKKHLLRHQPANAQIGLMEGNTFCTTLQPRLFTMDLNVVEHKVFYTELLNLCEAEDSALTKLPCYKSLPSLVPLRIAALNALAACNYLPQSREKIIAALFKALNSTNSELQEAGEACMRKFLEGATIEVDQIHTHMRPLLMMLGDYRSLTLNVVNRLTSVTRLFPNSFNDKFCDQMMQHLRKWMEVVVITHKGGQRSDGNESISECGRCPLSPFCQFEEMKICSAIINLFHLIPAAPQTLVKPLLEVVMKTERAMLIEAGSPFREPLIKFLTRHPSQTVELFMMEATLNDPQWSRMFMSFLKHKDARPLRDVLAANPNRFITLLLPGGAQTAVRPGSPSTSTMRLDLQFQAIKIISIIVKNDDSWLASQHSLVSQLRRVWVSENFQERHRKENMAATNWKEPKLLAYCLLNYCKRNYGDIELLFQLLRAFTGRFLCNMTFLKEYMEEEIPKNYSIAQKRALFFRFVDFNDPNFGDELKAKVLQHILNPAFLYSFEKGEGEQLLGPPNPEGDNPESITSVFITKVLDPEKQADMLDSLRIYLLQYATLLVEHAPHHIHDNNKNRNSKLRRLMTFAWPCLLSKACVDPACKYSGHLLLAHIIAKFAIHKKIVLQVFHSLLKAHAMEARAIVRQAMAILTPAVPARMEDGHQMLTHWTRKIIVEEGHTVPQLVHILHLIVQHFKVYYPVRHHLVQHMVSAMQRLGFTPSVTIEQRRLAVDLSEVVIKWELQRIKDQQPDSDMDPNSSGEGVNSVSSSIKRGLSVDSAQEVKRFRTATGAISAVFGRSQSLPGADSLLAKPIDKQHTDTVVNFLIRVACQVNDNTNTAGSPGEVLSRRCVNLLKTALRPDMWPKSELKLQWFDKLLMTVEQPNQVNYGNICTGLEVLSFLLTVLQSPAILSSFKPLQRGIAACMTCGNTKVLRAVHSLLSRLMSIFPTEPSTSSVASKYEELECLYAAVGKVIYEGLTNYEKATNANPSQLFGTLMILKSACSNNPSYIDRLISVFMRSLQKMVREHLNPQAASGSTEATSGTSELVMLSLELVKTRLAVMSMEMRKNFIQAILTSLIEKSPDAKILRAVVKIVEEWVKNNSPMAANQTPTLREKSILLVKMMTYIEKRFPEDLELNAQFLDLVNYVYRDETLSGSELTAKLEPAFLSGLRCAQPLIRAKFFEVFDNSMKRRVYERLLYVTCSQNWEAMGNHFWIKQCIELLLAVCEKSTPIGTSCQGAMLPSITNVINLADSHDRAAFAMVTHVKQEPRERENSESKEEDVEIDIELAPGDQTSTPKTKELSEKDIGNQLHMLTNRHDKFLDTLREVKTGALLSAFVQLCHISTTLAEKTWVQLFPRLWKILSDRQQHALAGEISPFLCSGSHQVQRDCQPSALNCFVEAMSQCVPPIPIRPCVLKYLGKTHNLWFRSTLMLEHQAFEKGLSLQIKPKQTTEFYEQESITPPQQEILDSLAELYSLLQEEDMWAGLWQKRCKYSETATAIAYEQHGFFEQAQESYEKAMDKAKKEHERSNASPAIFPEYQLWEDHWIRCSKELNQWEALTEYGQSKGHINPYLVLECAWRVSNWTAMKEALVQVEVSCPKEMAWKVNMYRGYLAICHPEEQQLSFIERLVEMASSLAIREWRRLPHVVSHVHTPLLQAAQQIIELQEAAQINAGLQPTNLGRNNSLHDMKTVVKTWRNRLPIVSDDLSHWSSIFMWRQHHYQGKPTWSGMHSSSIVTAYENSSQHDPSSNNAMLGVHASASAIIQYGKIARKQGLVNVALDILSRIHTIPTVPIVDCFQKIRQQVKCYLQLAGVMGKNECMQGLEVIESTNLKYFTKEMTAEFYALKGMFLAQINKSEEANKAFSAAVQMHDVLVKAWAMWGDYLENIFVKERQLHLGVSAITCYLHACRHQNESKSRKYLAKVLWLLSFDDDKNTLADAVDKYCIGVPPIQWLAWIPQLLTCLVGSEGKLLLNLISQVGRVYPQAVYFPIRTLYLTLKIEQRERYKSDPGPIRATAPMWRCSRIMHMQRELHPTLLSSLEGIVDQMVWFRENWHEEVLRQLQQGLAKCYSVAFEKSGAVSDAKITPHTLNFVKKLVSTFGVGLENVSNVSTMFSSAASESLARRAQATAQDPVFQKLKGQFTTDFDFSVPGSMKLHNLISKLKKWIKILEAKTKQLPKFFLIEEKCRFLSNFSAQTAEVEIPGEFLMPKPTHYYIKIARFMPRVEIVQKHNTAARRLYIRGHNGKIYPYLVMNDACLTESRREERVLQLLRLLNPCLEKRKETTKRHLFFTVPRVVAVSPQMRLVEDNPSSLSLVEIYKQRCAKKGIEHDNPISRYYDRLATVQARGTQASHQVLRDILKEVQSNMVPRSMLKEWALHTFPNATDYWTFRKMFTIQLALIGFAEFVLHLNRLNPEMLQIAQDTGKLNVAYFRFDINDATGDLDANRPVPFRLTPNISEFLTTIGVSGPLTASMIAVARCFAQPNFKVDGILKTVLRDEIIAWHKKTQEDTSSPLSAAGQPENMDSQQLVSLVQKAVTAIMTRLHNLAQFEGGESKVNTLVAAANSLDNLCRMDPAWHPWL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAFVATQGA
------CCCCCCCCC
20.9422223895
15PhosphorylationGATVVDQTTLMKKYL
CCEEECHHHHHHHHH
19.8922210691
16PhosphorylationATVVDQTTLMKKYLQ
CEEECHHHHHHHHHH
21.1522210691
19UbiquitinationVDQTTLMKKYLQFVA
ECHHHHHHHHHHHHH
41.18-
20UbiquitinationDQTTLMKKYLQFVAA
CHHHHHHHHHHHHHH
36.91-
21PhosphorylationQTTLMKKYLQFVAAL
HHHHHHHHHHHHHHH
10.5422210691
71PhosphorylationHIIPRFLTFLQDGEV
HHHHHHHHHHHCCCC
21.4230622161
84UbiquitinationEVQFLQEKPAQQLRK
CCCCCCCCHHHHHHH
32.4622817900
84 (in isoform 1)Ubiquitination-32.4621890473
84 (in isoform 2)Ubiquitination-32.4621890473
163UbiquitinationDFVKQIYKELPKVVN
HHHHHHHHHHHHHHH
55.1729967540
167UbiquitinationQIYKELPKVVNRYFE
HHHHHHHHHHHHHCC
72.0129967540
207PhosphorylationVNPEREDSETRTHSI
CCCCCCCCCCCCCCC
35.7923917254
209PhosphorylationPEREDSETRTHSIIP
CCCCCCCCCCCCCCC
44.83-
211PhosphorylationREDSETRTHSIIPRG
CCCCCCCCCCCCCCC
27.65-
213PhosphorylationDSETRTHSIIPRGSL
CCCCCCCCCCCCCCC
22.9223917254
219PhosphorylationHSIIPRGSLSLKVLA
CCCCCCCCCHHHHHH
18.9624719451
221PhosphorylationIIPRGSLSLKVLAEL
CCCCCCCHHHHHHHC
28.0424719451
221 (in isoform 2)Phosphorylation-28.0424719451
318PhosphorylationKGMLQLLSNCPAETA
HHHHHHHHCCCHHHH
45.00-
324PhosphorylationLSNCPAETAHLRKEL
HHCCCHHHHHHHHHH
22.83-
329UbiquitinationAETAHLRKELLIAAK
HHHHHHHHHHHHHHH
60.1029901268
336AcetylationKELLIAAKHILTTEL
HHHHHHHHHHHCHHH
23.3526051181
353UbiquitinationQFIPCMDKLFDESIL
CCCHHHHHHCCCCEE
24.95-
434PhosphorylationVDCIRSKSEQESGNG
HHHHHCCCHHHCCCH
45.84-
458PhosphorylationVFVLKFHTIARYQLS
HHHHHHHHHHHHHHH
21.3320068231
470UbiquitinationQLSAIFKKCKPQSEL
HHHHHHHHCCCHHHH
36.42-
538UbiquitinationGEKDKEDKQTFQVTD
CCCCCCCCCCEEHHH
52.9429967540
544PhosphorylationDKQTFQVTDCRSLVK
CCCCEEHHHHHHHHH
20.7124719451
544 (in isoform 2)Phosphorylation-20.7124719451
548PhosphorylationFQVTDCRSLVKTLVC
EEHHHHHHHHHHHHC
43.7929083192
551AcetylationTDCRSLVKTLVCGVK
HHHHHHHHHHHCCCE
41.2426051181
551UbiquitinationTDCRSLVKTLVCGVK
HHHHHHHHHHHCCCE
41.24-
552PhosphorylationDCRSLVKTLVCGVKT
HHHHHHHHHHCCCEE
19.5529083192
559PhosphorylationTLVCGVKTITWGITS
HHHCCCEEEEECCCC
22.6429083192
561PhosphorylationVCGVKTITWGITSCK
HCCCEEEEECCCCCC
23.9129083192
565PhosphorylationKTITWGITSCKAPGE
EEEEECCCCCCCCCC
24.9229083192
566PhosphorylationTITWGITSCKAPGEA
EEEECCCCCCCCCCC
16.2329083192
568UbiquitinationTWGITSCKAPGEAQF
EECCCCCCCCCCCCC
58.33-
579UbiquitinationEAQFIPNKQLQPKET
CCCCCCCCCCCCCCH
47.2121906983
579 (in isoform 1)Ubiquitination-47.2121890473
579 (in isoform 2)Ubiquitination-47.2121890473
584UbiquitinationPNKQLQPKETQIYIK
CCCCCCCCCHHHHHH
61.5022817900
586PhosphorylationKQLQPKETQIYIKLV
CCCCCCCHHHHHHHH
26.7926552605
589PhosphorylationQPKETQIYIKLVKYA
CCCCHHHHHHHHHHH
5.1226552605
595PhosphorylationIYIKLVKYAMQALDI
HHHHHHHHHHHHCCE
10.3826552605
603PhosphorylationAMQALDIYQVQIAGN
HHHHCCEEEEEECCC
11.4226552605
613PhosphorylationQIAGNGQTYIRVANC
EECCCCCEEEEEECC
23.4726552605
614PhosphorylationIAGNGQTYIRVANCQ
ECCCCCEEEEEECCC
4.4626552605
663PhosphorylationPYMVERISKNYALQI
HHHHHHHCCCHHHHH
22.52-
744SulfoxidationHKIVNSSMELAQTAK
HHHHHHHHHHHHHCC
4.9921406390
818PhosphorylationLTVPVRLSSLLPYLP
HCCCCHHHHHHHHHH
14.3624043423
819PhosphorylationTVPVRLSSLLPYLPM
CCCCHHHHHHHHHHH
38.2224043423
823PhosphorylationRLSSLLPYLPMLMDP
HHHHHHHHHHHHHHH
24.3324043423
833PhosphorylationMLMDPLVSALNGSQT
HHHHHHHHHHCCCHH
34.4224043423
838PhosphorylationLVSALNGSQTLVSQG
HHHHHCCCHHHHHCC
20.9324043423
840PhosphorylationSALNGSQTLVSQGLR
HHHCCCHHHHHCCCC
30.7224043423
843PhosphorylationNGSQTLVSQGLRTLE
CCCHHHHHCCCCHHH
22.9524043423
862PhosphorylationNLQPDFLYDHIQPVR
HCCCCCHHHCCHHHH
12.88-
886PhosphorylationTLRNPADSISHVAYR
HHCCHHHHHHHHHHH
28.2629759185
888PhosphorylationRNPADSISHVAYRVL
CCHHHHHHHHHHHHH
18.8329759185
897UbiquitinationVAYRVLGKFGGSNRK
HHHHHHHHCCCCCHH
36.3521890473
897UbiquitinationVAYRVLGKFGGSNRK
HHHHHHHHCCCCCHH
36.3527667366
897 (in isoform 1)Ubiquitination-36.3521890473
897 (in isoform 2)Ubiquitination-36.3521890473
914PhosphorylationKESQKLHYVVTEVQG
HHHHHCEEEEEEEEC
13.67-
917PhosphorylationQKLHYVVTEVQGPSI
HHCEEEEEEEECCEE
22.01-
923PhosphorylationVTEVQGPSITVEFSD
EEEEECCEEEEEECC
37.40-
929PhosphorylationPSITVEFSDCKASLQ
CEEEEEECCCCHHCC
28.70-
934PhosphorylationEFSDCKASLQLPMEK
EECCCCHHCCCCHHH
11.35-
941UbiquitinationSLQLPMEKAIETALD
HCCCCHHHHHHHHHH
48.70-
951UbiquitinationETALDCLKSANTEPY
HHHHHHHHHCCCCHH
54.5832015554
996UbiquitinationAHPNFTEKTIPNVII
HCCCCCCCCCCCEEE
49.0129967540
1007PhosphorylationNVIISHRYKAQDTPA
CEEEEECCCCCCCCC
12.78-
1016UbiquitinationAQDTPARKTFEQALT
CCCCCCHHHHHHHHH
60.72-
1044PhosphorylationSALPFVASLIRHYTM
HHHHHHHHHHHHHHH
21.01-
1139O-linked_GlycosylationACQLPLFSYIVERLC
HCCCHHHHHHHHHHH
22.9530379171
1195PhosphorylationLFVMMDLTGEVSNGA
HHHHHHHCCCCCHHH
27.3429083192
1199PhosphorylationMDLTGEVSNGAVAMA
HHHCCCCCHHHHHHH
25.8329083192
1208PhosphorylationGAVAMAKTTLEQLLM
HHHHHHHHHHHHHHH
27.3721406692
1209PhosphorylationAVAMAKTTLEQLLMR
HHHHHHHHHHHHHHH
27.8221406692
1215SulfoxidationTTLEQLLMRCATPLK
HHHHHHHHHHCCCCC
4.4921406390
1222UbiquitinationMRCATPLKDEERAEE
HHHCCCCCCHHHHHH
65.3829967540
1236UbiquitinationEIVAAQEKSFHHVTH
HHHHHHHHHHHHCHH
46.4729967540
1263PhosphorylationVRKQAMHSLQVLAQV
HHHHHHHHHHHHHHH
13.8621406692
1271PhosphorylationLQVLAQVTGKSVTVI
HHHHHHHHCCEEEEE
27.1521406692
1357UbiquitinationLTKLPCYKSLPSLVP
HHCCCCCCCCCCHHH
52.84-
1385UbiquitinationYLPQSREKIIAALFK
CCCCCHHHHHHHHHH
38.00-
1396PhosphorylationALFKALNSTNSELQE
HHHHHHHCCCHHHHH
29.8022210691
1437PhosphorylationLLMMLGDYRSLTLNV
HHHHHCCHHHCHHHH
10.58-
1439PhosphorylationMMLGDYRSLTLNVVN
HHHCCHHHCHHHHHH
21.3420068231
1441PhosphorylationLGDYRSLTLNVVNRL
HCCHHHCHHHHHHHH
19.9620068231
1441 (in isoform 2)Phosphorylation-19.96-
1458PhosphorylationVTRLFPNSFNDKFCD
HHHHCCCCCCHHHHH
26.18-
1534 (in isoform 2)Phosphorylation-34.40-
1552PhosphorylationAMLIEAGSPFREPLI
HHHHHCCCCCCHHHH
28.1020068231
1590PhosphorylationQWSRMFMSFLKHKDA
HHHHHHHHHHHCCCC
19.0324719451
1593AcetylationRMFMSFLKHKDARPL
HHHHHHHHCCCCCCH
46.7426051181
1610 (in isoform 2)Phosphorylation-26.12-
1613PhosphorylationANPNRFITLLLPGGA
HCCCCEEEEEECCCC
14.5124732914
1615 (in isoform 2)Phosphorylation-3.98-
1622PhosphorylationLLPGGAQTAVRPGSP
EECCCCCEEECCCCC
26.9625022875
1628PhosphorylationQTAVRPGSPSTSTMR
CEEECCCCCCCCCEE
20.5421082442
1630PhosphorylationAVRPGSPSTSTMRLD
EECCCCCCCCCEEEE
36.3725022875
1631PhosphorylationVRPGSPSTSTMRLDL
ECCCCCCCCCEEEEE
31.4430631047
1632PhosphorylationRPGSPSTSTMRLDLQ
CCCCCCCCCEEEEEH
25.2530631047
1633PhosphorylationPGSPSTSTMRLDLQF
CCCCCCCCEEEEEHH
13.3421712546
1647PhosphorylationFQAIKIISIIVKNDD
HCEEEEEEEEECCCC
15.1020068231
1691MethylationNMAATNWKEPKLLAY
CCCCCCCCCHHHHHH
67.2323644510
1731UbiquitinationRFLCNMTFLKEYMEE
HHHHCCHHHHHHHHH
6.8027667366
1749UbiquitinationKNYSIAQKRALFFRF
CCCCHHHHHHHEEEE
30.5327667366
1751UbiquitinationYSIAQKRALFFRFVD
CCHHHHHHHEEEECC
18.7622817900
1751 (in isoform 2)Ubiquitination-18.7621890473
1753UbiquitinationIAQKRALFFRFVDFN
HHHHHHHEEEECCCC
3.9422817900
1769UbiquitinationPNFGDELKAKVLQHI
CCCCHHHHHHHHHHH
44.0821906983
1769 (in isoform 1)Ubiquitination-44.0821890473
1771UbiquitinationFGDELKAKVLQHILN
CCHHHHHHHHHHHHC
41.7222817900
1796UbiquitinationEGEQLLGPPNPEGDN
CCCCCCCCCCCCCCC
26.0123503661
1796 (in isoform 2)Ubiquitination-26.01-
1802UbiquitinationGPPNPEGDNPESITS
CCCCCCCCCCHHCCE
66.8923503661
1814UbiquitinationITSVFITKVLDPEKQ
CCEEEEEECCCHHHH
35.6623503661
1820UbiquitinationTKVLDPEKQADMLDS
EECCCHHHHHHHHHH
57.0623503661
1907PhosphorylationIVLQVFHSLLKAHAM
HHHHHHHHHHHHHHH
24.7524719451
1987PhosphorylationHLVQHMVSAMQRLGF
HHHHHHHHHHHHCCC
15.5026074081
1995PhosphorylationAMQRLGFTPSVTIEQ
HHHHCCCCCCCCEEE
16.9226074081
1997PhosphorylationQRLGFTPSVTIEQRR
HHCCCCCCCCEEEEE
28.9226074081
1999PhosphorylationLGFTPSVTIEQRRLA
CCCCCCCCEEEEECC
24.1226074081
2004UbiquitinationSVTIEQRRLAVDLSE
CCCEEEEECCCCHHH
27.0522817900
2004 (in isoform 2)Ubiquitination-27.0521890473
2022UbiquitinationKWELQRIKDQQPDSD
HHHHHHHHCCCCCCC
52.2321906983
2022 (in isoform 1)Ubiquitination-52.2321890473
2029UbiquitinationKDQQPDSDMDPNSSG
HCCCCCCCCCCCCCC
53.5422817900
2029 (in isoform 2)Ubiquitination-53.5421890473
2033 (in isoform 2)Phosphorylation-44.5424719451
2034PhosphorylationDSDMDPNSSGEGVNS
CCCCCCCCCCCCHHH
45.1415302935
2035PhosphorylationSDMDPNSSGEGVNSV
CCCCCCCCCCCHHHH
47.7228555341
2041UbiquitinationSSGEGVNSVSSSIKR
CCCCCHHHHHHHHHC
22.4429967540
2047AcetylationNSVSSSIKRGLSVDS
HHHHHHHHCCCCCCC
42.2226051181
2047UbiquitinationNSVSSSIKRGLSVDS
HHHHHHHHCCCCCCC
42.2221906983
2047 (in isoform 1)Ubiquitination-42.2221890473
2051PhosphorylationSSIKRGLSVDSAQEV
HHHHCCCCCCCHHHH
27.0529255136
2054PhosphorylationKRGLSVDSAQEVKRF
HCCCCCCCHHHHHHH
29.6925159151
2057 (in isoform 2)Phosphorylation-50.12-
2059AcetylationVDSAQEVKRFRTATG
CCCHHHHHHHHHHHH
45.1025953088
2059PhosphorylationVDSAQEVKRFRTATG
CCCHHHHHHHHHHHH
45.1032645325
2059UbiquitinationVDSAQEVKRFRTATG
CCCHHHHHHHHHHHH
45.1029967540
2059 (in isoform 2)Phosphorylation-45.1024719451
2063PhosphorylationQEVKRFRTATGAISA
HHHHHHHHHHHHHHH
26.3419835603
2065PhosphorylationVKRFRTATGAISAVF
HHHHHHHHHHHHHHH
26.9124173317
2069PhosphorylationRTATGAISAVFGRSQ
HHHHHHHHHHHCCCC
20.1819835603
2075PhosphorylationISAVFGRSQSLPGAD
HHHHHCCCCCCCCCC
25.2130266825
2077PhosphorylationAVFGRSQSLPGADSL
HHHCCCCCCCCCCHH
37.4725159151
2083PhosphorylationQSLPGADSLLAKPID
CCCCCCCHHCCCCCC
25.4230266825
2084PhosphorylationSLPGADSLLAKPIDK
CCCCCCHHCCCCCCC
5.7732645325
2087UbiquitinationGADSLLAKPIDKQHT
CCCHHCCCCCCCCCH
42.34-
2091UbiquitinationLLAKPIDKQHTDTVV
HCCCCCCCCCHHHHH
44.70-
2094PhosphorylationKPIDKQHTDTVVNFL
CCCCCCCHHHHHHHH
30.7624043423
2096PhosphorylationIDKQHTDTVVNFLIR
CCCCCHHHHHHHHHH
27.7524043423
2112PhosphorylationACQVNDNTNTAGSPG
HHEECCCCCCCCCHH
36.4924043423
2114PhosphorylationQVNDNTNTAGSPGEV
EECCCCCCCCCHHHH
30.2920068231
2114 (in isoform 2)Phosphorylation-30.29-
2117PhosphorylationDNTNTAGSPGEVLSR
CCCCCCCCHHHHHHH
27.5424043423
2123PhosphorylationGSPGEVLSRRCVNLL
CCHHHHHHHHHHHHH
23.9024043423
2123UbiquitinationGSPGEVLSRRCVNLL
CCHHHHHHHHHHHHH
23.9029967540
2127UbiquitinationEVLSRRCVNLLKTAL
HHHHHHHHHHHHHHH
5.5429967540
2132PhosphorylationRCVNLLKTALRPDMW
HHHHHHHHHHCCCCC
30.7820068231
2141UbiquitinationLRPDMWPKSELKLQW
HCCCCCCHHHHHHHH
40.8429967540
2145UbiquitinationMWPKSELKLQWFDKL
CCCHHHHHHHHHHHH
34.2829967540
2207UbiquitinationCMTCGNTKVLRAVHS
HHHCCCHHHHHHHHH
43.18-
2214PhosphorylationKVLRAVHSLLSRLMS
HHHHHHHHHHHHHHH
25.1424719451
2217PhosphorylationRAVHSLLSRLMSIFP
HHHHHHHHHHHHHCC
28.7624719451
2221PhosphorylationSLLSRLMSIFPTEPS
HHHHHHHHHCCCCCC
26.1820071362
2225PhosphorylationRLMSIFPTEPSTSSV
HHHHHCCCCCCCCHH
50.1820071362
2228PhosphorylationSIFPTEPSTSSVASK
HHCCCCCCCCHHHHH
34.3920071362
2230PhosphorylationFPTEPSTSSVASKYE
CCCCCCCCHHHHHHH
27.4420071362
2231PhosphorylationPTEPSTSSVASKYEE
CCCCCCCHHHHHHHH
23.0720071362
2234PhosphorylationPSTSSVASKYEELEC
CCCCHHHHHHHHHHH
33.3520071362
2235AcetylationSTSSVASKYEELECL
CCCHHHHHHHHHHHH
47.1269679
2251PhosphorylationAAVGKVIYEGLTNYE
HHHHHHHHHCCCCHH
13.6128152594
2284PhosphorylationSACSNNPSYIDRLIS
HHHCCCHHHHHHHHH
36.52-
2291PhosphorylationSYIDRLISVFMRSLQ
HHHHHHHHHHHHHHH
17.5621406692
2296PhosphorylationLISVFMRSLQKMVRE
HHHHHHHHHHHHHHH
24.3021406692
2311PhosphorylationHLNPQAASGSTEATS
HCCCCCCCCCCCCCC
35.9722210691
2313PhosphorylationNPQAASGSTEATSGT
CCCCCCCCCCCCCCC
22.1522210691
2315 (in isoform 2)Phosphorylation-52.20-
2333PhosphorylationLSLELVKTRLAVMSM
HHHHHHHHHHHHHCH
24.3617192257
2339PhosphorylationKTRLAVMSMEMRKNF
HHHHHHHCHHHHHHH
12.6522210691
2339UbiquitinationKTRLAVMSMEMRKNF
HHHHHHHCHHHHHHH
12.6523000965
2344UbiquitinationVMSMEMRKNFIQAIL
HHCHHHHHHHHHHHH
55.7023000965
2352PhosphorylationNFIQAILTSLIEKSP
HHHHHHHHHHHHHCC
18.5120068231
2353PhosphorylationFIQAILTSLIEKSPD
HHHHHHHHHHHHCCC
24.7324719451
2357UbiquitinationILTSLIEKSPDAKIL
HHHHHHHHCCCHHHH
61.3623000965
2362UbiquitinationIEKSPDAKILRAVVK
HHHCCCHHHHHHHHH
50.0523000965
2369UbiquitinationKILRAVVKIVEEWVK
HHHHHHHHHHHHHHH
34.1433845483
2374UbiquitinationVVKIVEEWVKNNSPM
HHHHHHHHHHCCCCC
7.9029967540
2383 (in isoform 2)Phosphorylation-11.47-
2392UbiquitinationQTPTLREKSILLVKM
CCCCHHHHHHHHHHH
36.0429967540
2401PhosphorylationILLVKMMTYIEKRFP
HHHHHHHHHHHHHCC
20.1822817900
2402PhosphorylationLLVKMMTYIEKRFPE
HHHHHHHHHHHHCCC
6.8120068231
2405MethylationKMMTYIEKRFPEDLE
HHHHHHHHHCCCCHH
50.1823644510
2405UbiquitinationKMMTYIEKRFPEDLE
HHHHHHHHHCCCCHH
50.18-
2420UbiquitinationLNAQFLDLVNYVYRD
HHHHHHHHHHHHHCC
2.6822817900
2420 (in isoform 2)Ubiquitination-2.6821890473
2438UbiquitinationSGSELTAKLEPAFLS
CCCHHHHHCHHHHHH
48.4222817900
2438 (in isoform 1)Ubiquitination-48.4221890473
2445PhosphorylationKLEPAFLSGLRCAQP
HCHHHHHHCCCCCHH
29.3624719451
2457UbiquitinationAQPLIRAKFFEVFDN
CHHHHHHHHHHHCCC
40.51-
2520PhosphorylationCQGAMLPSITNVINL
CCCCCCCCHHCHHHH
37.7830301811
2522PhosphorylationGAMLPSITNVINLAD
CCCCCCHHCHHHHCC
27.9829083192
2525AcetylationLPSITNVINLADSHD
CCCHHCHHHHCCCCC
3.6619608861
2525 (in isoform 2)Acetylation-3.66-
2530PhosphorylationNVINLADSHDRAAFA
CHHHHCCCCCHHHHH
22.9821712546
2536 (in isoform 2)Phosphorylation-4.3824719451
2543AcetylationFAMVTHVKQEPRERE
HHHHHHHHCCCCCCC
41.1423954790
2543SumoylationFAMVTHVKQEPRERE
HHHHHHHHCCCCCCC
41.1428112733
2543UbiquitinationFAMVTHVKQEPRERE
HHHHHHHHCCCCCCC
41.1419608861
2552PhosphorylationEPRERENSESKEEDV
CCCCCCCCCCCCCCE
38.1925849741
2554PhosphorylationRERENSESKEEDVEI
CCCCCCCCCCCCEEE
45.2330266825
2564UbiquitinationEDVEIDIELAPGDQT
CCEEEEEEECCCCCC
34.8229967540
2571PhosphorylationELAPGDQTSTPKTKE
EECCCCCCCCCCCCC
39.0325159151
2572PhosphorylationLAPGDQTSTPKTKEL
ECCCCCCCCCCCCCC
36.7625627689
2573PhosphorylationAPGDQTSTPKTKELS
CCCCCCCCCCCCCCC
31.9925627689
2579UbiquitinationSTPKTKELSEKDIGN
CCCCCCCCCHHHHHH
9.5021890473
2579UbiquitinationSTPKTKELSEKDIGN
CCCCCCCCCHHHHHH
9.5021890473
2579 (in isoform 2)Ubiquitination-9.5021890473
2582AcetylationKTKELSEKDIGNQLH
CCCCCCHHHHHHHHH
51.8025953088
2582UbiquitinationKTKELSEKDIGNQLH
CCCCCCHHHHHHHHH
51.8029967540
2583 (in isoform 2)Phosphorylation-50.40-
2597UbiquitinationMLTNRHDKFLDTLRE
HHHHCHHHHHHHHHH
41.5221890473
2597 (in isoform 1)Ubiquitination-41.5221890473
2601PhosphorylationRHDKFLDTLREVKTG
CHHHHHHHHHHHHHH
29.8417192257
2620UbiquitinationAFVQLCHISTTLAEK
HHHHHHHHHHHHHHH
3.6921890473
2620UbiquitinationAFVQLCHISTTLAEK
HHHHHHHHHHHHHHH
3.6921890473
2620 (in isoform 2)Ubiquitination-3.6921890473
2638UbiquitinationQLFPRLWKILSDRQQ
HHHHHHHHHHCHHHH
38.0621890473
2638 (in isoform 1)Ubiquitination-38.0621890473
2706UbiquitinationTHNLWFRSTLMLEHQ
CCCCCHHHHHHHHHH
19.2029967540
2724AcetylationKGLSLQIKPKQTTEF
CCCCCEECCCCCCCC
32.9525953088
2724UbiquitinationKGLSLQIKPKQTTEF
CCCCCEECCCCCCCC
32.9529967540
2811UbiquitinationHERSNASPAIFPEYQ
HHHHCCCCCCCCHHH
27.2829967540
2829UbiquitinationDHWIRCSKELNQWEA
HHHHHHCHHHHHHHH
70.6029967540
2950UbiquitinationLQEAAQINAGLQPTN
HHHHHHHCCCCCCCC
18.8422817900
2954UbiquitinationAQINAGLQPTNLGRN
HHHCCCCCCCCCCCC
41.6821890473
2954UbiquitinationAQINAGLQPTNLGRN
HHHCCCCCCCCCCCC
41.6821890473
2954 (in isoform 2)Ubiquitination-41.6821890473
2968UbiquitinationNNSLHDMKTVVKTWR
CCCHHHHHHHHHHHH
44.2022817900
2972UbiquitinationHDMKTVVKTWRNRLP
HHHHHHHHHHHHCCC
37.7321890473
2972 (in isoform 1)Ubiquitination-37.7321890473
3017UbiquitinationSSSIVTAYENSSQHD
CHHHEEEEECCCCCC
13.2822817900
3021UbiquitinationVTAYENSSQHDPSSN
EEEEECCCCCCCCCC
43.0221890473
3021UbiquitinationVTAYENSSQHDPSSN
EEEEECCCCCCCCCC
43.0221890473
3021 (in isoform 2)Ubiquitination-43.0221890473
3046UbiquitinationSAIIQYGKIARKQGL
HHHHHHHHHHHHCCH
28.4022817900
3049AcetylationIQYGKIARKQGLVNV
HHHHHHHHHCCHHHH
34.9919608861
3049UbiquitinationIQYGKIARKQGLVNV
HHHHHHHHHCCHHHH
34.9919608861
3049 (in isoform 2)Acetylation-34.99-
3050UbiquitinationQYGKIARKQGLVNVA
HHHHHHHHCCHHHHH
39.4321890473
3050 (in isoform 1)Ubiquitination-39.4321890473
3078AcetylationPIVDCFQKIRQQVKC
CHHHHHHHHHHHHHH
21.4319608861
3078UbiquitinationPIVDCFQKIRQQVKC
CHHHHHHHHHHHHHH
21.4319608861
3082UbiquitinationCFQKIRQQVKCYLQL
HHHHHHHHHHHHHHH
27.1329967540
3111UbiquitinationVIESTNLKYFTKEMT
EECCCCCHHCCHHHH
40.1529967540
3122PhosphorylationKEMTAEFYALKGMFL
HHHHHHHHHHHHHHH
11.5219835603
3154 (in isoform 2)Phosphorylation-33.77-
3178PhosphorylationRQLHLGVSAITCYLH
CCCCCCHHHHHHHHH
16.5020068231
3181PhosphorylationHLGVSAITCYLHACR
CCCHHHHHHHHHHHH
8.5320068231
3183PhosphorylationGVSAITCYLHACRHQ
CHHHHHHHHHHHHCC
7.9020068231
3193PhosphorylationACRHQNESKSRKYLA
HHHCCCHHHCHHHHH
43.4020068231
3255PhosphorylationKLLLNLISQVGRVYP
HHHHHHHHHHCCCCC
23.2120886841
3286PhosphorylationEQRERYKSDPGPIRA
HHHHHHCCCCCCCCC
39.8520860994
3316PhosphorylationELHPTLLSSLEGIVD
HHCHHHHHHHHHHHH
35.6722210691
3317PhosphorylationLHPTLLSSLEGIVDQ
HCHHHHHHHHHHHHH
30.3422210691
3343UbiquitinationVLRQLQQGLAKCYSV
HHHHHHHHHHHHHHH
18.0322817900
3343 (in isoform 2)Ubiquitination-18.0321890473
3344UbiquitinationLRQLQQGLAKCYSVA
HHHHHHHHHHHHHHH
3.4222817900
3346UbiquitinationQLQQGLAKCYSVAFE
HHHHHHHHHHHHHHH
38.45-
3354UbiquitinationCYSVAFEKSGAVSDA
HHHHHHHCCCCCCCC
47.97-
3362AcetylationSGAVSDAKITPHTLN
CCCCCCCCCCHHHHH
52.7025953088
3362UbiquitinationSGAVSDAKITPHTLN
CCCCCCCCCCHHHHH
52.70-
3372UbiquitinationPHTLNFVKKLVSTFG
HHHHHHHHHHHHHHC
35.9321906983
3372 (in isoform 1)Ubiquitination-35.9321890473
3373UbiquitinationHTLNFVKKLVSTFGV
HHHHHHHHHHHHHCC
49.1422817900
3376PhosphorylationNFVKKLVSTFGVGLE
HHHHHHHHHHCCCCC
28.5820860994
3386PhosphorylationGVGLENVSNVSTMFS
CCCCCCCCCHHHHHC
42.9920860994
3386UbiquitinationGVGLENVSNVSTMFS
CCCCCCCCCHHHHHC
42.9933845483
3386 (in isoform 2)Ubiquitination-42.9921890473
3388UbiquitinationGLENVSNVSTMFSSA
CCCCCCCHHHHHCHH
3.8222817900
3389PhosphorylationLENVSNVSTMFSSAA
CCCCCCHHHHHCHHH
20.5720860994
3390PhosphorylationENVSNVSTMFSSAAS
CCCCCHHHHHCHHHH
20.2520860994
3399PhosphorylationFSSAASESLARRAQA
HCHHHHHHHHHHHHH
25.4920860994
3415UbiquitinationAQDPVFQKLKGQFTT
HCCHHHHHHCCCCCC
40.4721906983
3415 (in isoform 1)Ubiquitination-40.4721890473
3417UbiquitinationDPVFQKLKGQFTTDF
CHHHHHHCCCCCCCC
58.6722817900
3429UbiquitinationTDFDFSVPGSMKLHN
CCCCCCCCCHHHHHH
28.1333845483
3442UbiquitinationHNLISKLKKWIKILE
HHHHHHHHHHHHHHH
50.20-
3451AcetylationWIKILEAKTKQLPKF
HHHHHHHHHCCCCCE
47.0525953088
3464UbiquitinationKFFLIEEKCRFLSNF
CEEHHHHHHHHHHCC
20.23-
3469PhosphorylationEEKCRFLSNFSAQTA
HHHHHHHHCCCCCCC
32.87-
3488UbiquitinationPGEFLMPKPTHYYIK
CCCCCCCCCCEEEEE
48.89-
3508UbiquitinationPRVEIVQKHNTAARR
CCEEHHHHCCHHHHH
28.11-
3526PhosphorylationRGHNGKIYPYLVMND
ECCCCCEEEEEEECC
6.84-
3529UbiquitinationNGKIYPYLVMNDACL
CCCEEEEEEECCCCC
2.2624816145
3558UbiquitinationLLNPCLEKRKETTKR
HHHHHHHHCCCCCHH
56.6824816145
3569UbiquitinationTTKRHLFFTVPRVVA
CCHHHHEEECCEEEE
9.4222817900
3569 (in isoform 2)Ubiquitination-9.4221890473
3574UbiquitinationLFFTVPRVVAVSPQM
HEEECCEEEEECCCC
2.3722817900
3575UbiquitinationFFTVPRVVAVSPQMR
EEECCEEEEECCCCC
4.6123503661
3598AcetylationLSLVEIYKQRCAKKG
CHHHHHHHHHHHHCC
36.6126051181
3598UbiquitinationLSLVEIYKQRCAKKG
CHHHHHHHHHHHHCC
36.6121906983
3598 (in isoform 1)Ubiquitination-36.6121890473
3603UbiquitinationIYKQRCAKKGIEHDN
HHHHHHHHCCCCCCC
55.9822817900
3604UbiquitinationYKQRCAKKGIEHDNP
HHHHHHHCCCCCCCH
46.7423503661
3610UbiquitinationKKGIEHDNPISRYYD
HCCCCCCCHHHHHHH
37.4022817900
3610 (in isoform 2)Ubiquitination-37.4021890473
3618MethylationPISRYYDRLATVQAR
HHHHHHHHHHHHHCC
15.31115919037
3639UbiquitinationQVLRDILKEVQSNMV
HHHHHHHHHHHHCCC
57.0622817900
3639 (in isoform 1)Ubiquitination-57.0621890473
3643PhosphorylationDILKEVQSNMVPRSM
HHHHHHHHCCCCHHH
31.8823403867
3709PhosphorylationTGKLNVAYFRFDIND
HCCCEEEEEEEEECC
7.33-
3765UbiquitinationCFAQPNFKVDGILKT
HHCCCCCEECCHHHH
46.16-
3772PhosphorylationKVDGILKTVLRDEII
EECCHHHHHHHHHHH
22.7124719451
3790PhosphorylationKKTQEDTSSPLSAAG
HCCCCCCCCCCCCCC
42.1325627689
3791PhosphorylationKTQEDTSSPLSAAGQ
CCCCCCCCCCCCCCC
31.7725627689
3805UbiquitinationQPENMDSQQLVSLVQ
CCCCCCHHHHHHHHH
36.0432015554
3834UbiquitinationQFEGGESKVNTLVAA
HHCCCHHHHHHHHHH
34.8932015554
3848UbiquitinationAANSLDNLCRMDPAW
HHHCHHHHHCCCCCC
1.6332015554

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseCDC20Q12834
PMID:23318449
-KUbiquitinationE3 ubiquitin ligaseFZR1Q9UM11
PMID:23318449

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TRRAP_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TRRAP_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EP400_HUMANEP400physical
11509179
ATX7_HUMANATXN7physical
16494529
KAT2A_HUMANKAT2Aphysical
16494529
P53_HUMANTP53physical
12138177
MED1_HUMANMED1physical
18418385
MED23_HUMANMED23physical
18418385
KAT2A_HUMANKAT2Aphysical
18418385
MED26_HUMANMED26physical
18418385
CDK8_HUMANCDK8physical
18418385
MED12_HUMANMED12physical
18418385
MED13_HUMANMED13physical
18418385
MED14_HUMANMED14physical
18418385
MED15_HUMANMED15physical
18418385
MED16_HUMANMED16physical
18418385
MED17_HUMANMED17physical
18418385
MED24_HUMANMED24physical
18418385
MED25_HUMANMED25physical
18418385
MYC_HUMANMYCphysical
11511539
NPAT_HUMANNPATphysical
17967892
KAT2A_HUMANKAT2Aphysical
20508642
SGF29_HUMANCCDC101physical
20508642
UL27_HCMVMUL27physical
21320693
NPAT_HUMANNPATphysical
22288532
SRBP2_HUMANSREBF2physical
22288532
CDN1A_HUMANCDKN1Aphysical
12897156
SKP1_HUMANSKP1physical
19066453
CUL1_HUMANCUL1physical
19066453
MRE11_HUMANMRE11Aphysical
23318449
CDC20_HUMANCDC20physical
23318449
TAF5_HUMANTAF5physical
15870280
TAF6_HUMANTAF6physical
15870280
UBP7_HUMANUSP7physical
25925205
BTAF1_HUMANBTAF1physical
26344197
VPS72_HUMANVPS72physical
26496610
YETS4_HUMANYEATS4physical
26496610
SUPT3_HUMANSUPT3Hphysical
26496610
RUVB1_HUMANRUVBL1physical
26496610
TTI1_HUMANTTI1physical
26496610
ST65G_HUMANSUPT7Lphysical
26496610
TADA3_HUMANTADA3physical
26496610
RUVB2_HUMANRUVBL2physical
26496610
BRD8_HUMANBRD8physical
26496610
EPC2_HUMANEPC2physical
26496610
ING3_HUMANING3physical
26496610
SP20H_HUMANSUPT20Hphysical
26496610
DMAP1_HUMANDMAP1physical
26496610
EP400_HUMANEP400physical
26496610
TTI2_HUMANTTI2physical
26496610
EPC1_HUMANEPC1physical
26496610
TAD2B_HUMANTADA2Bphysical
26496610
SGF29_HUMANCCDC101physical
26496610
TADA1_HUMANTADA1physical
26496610
K2C72_HUMANKRT72physical
26496610
JAZF1_HUMANJAZF1physical
26496610
BRNP1_HUMANBRINP1physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TRRAP_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-2543 AND LYS-3078, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2051, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1628, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2051 AND SER-2077, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1628; SER-2051;SER-2077; THR-2333 AND THR-2601, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2051, AND MASSSPECTROMETRY.

TOP